Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Publication year range
1.
Reumatol. clín. (Barc.) ; 11(2): 112-115, mar.-abr. 2015. tab, ilus
Article in Spanish | IBECS | ID: ibc-133347

ABSTRACT

El síndrome de Noonan es un síndrome genético autosómico dominante que presenta una gran variabilidad fenotípica, caracterizado principalmente por dimorfismo facial, cardiopatía congénita y talla baja. Describimos el caso de un paciente de sexo masculino con síndrome de Noonan y espondiloartritis periférica, asociación no descrita en la literatura hasta el momento (AU)


Noonan's syndrome is an autosomal dominant genetic disorder with high phenotypic variability, characterized mainly by facial dysmorphism, congenital heart disease and short stature. We describe the case of a male patient diagnosed with Noonan's syndrome and peripheral spondyloarthritis, a previously undescribed association in the literature (AU)


Subject(s)
Humans , Male , Adult , Noonan Syndrome/complications , Noonan Syndrome/diagnosis , Spondylarthritis/complications , Spondylarthritis/diagnosis , Spondylarthritis/drug therapy , Arthritis/complications , Arthritis/drug therapy , Arthritis/genetics , Naproxen/therapeutic use , Spondylarthritis/physiopathology , Cardiomyopathy, Hypertrophic/complications , Pulmonary Valve Stenosis/complications , Diagnosis, Differential , Sulfasalazine/therapeutic use , Vitamin D/therapeutic use
2.
Reumatol Clin ; 11(2): 112-5, 2015.
Article in English, Spanish | MEDLINE | ID: mdl-24447602

ABSTRACT

Noonan's syndrome is an autosomal dominant genetic disorder with high phenotypic variability, characterized mainly by facial dysmorphism, congenital heart disease and short stature. We describe the case of a male patient diagnosed with Noonan's syndrome and peripheral spondyloarthritis, a previously undescribed association in the literature.


Subject(s)
Lumbar Vertebrae , Noonan Syndrome/complications , Sacrum , Spondylarthritis/etiology , Humans , Male , Spondylarthritis/diagnosis , Young Adult
3.
Rev. colomb. reumatol ; 20(2): 111-115, abr.-jun. 2013. tab
Article in Spanish | LILACS | ID: lil-683040

ABSTRACT

La artritis reumatoide es una enfermedad crónica, sistémica e inflamatoria, de etiología desconocida, que afecta, principalmente la membrana sinovial de las articulaciones. Se caracteriza por dolor crónico, y destrucción articular que conlleva un aumento de la mortalidad y un elevado riesgo de invalidez con altos costos para el enfermo y la sociedad. Describimos el caso de un paciente joven con anemia aplásica desde los 8 años, que inicia en 2009 cuadro de dolor y aumento de volumen articular en manos, muñecas y tobillos bilaterales, cumpliendo los criterios para artritis reumatoide.


Rheumatoid arthritis (RA) is a chronic, systemic, and inflammatory disease of unknown etiology that mainly affects the synovial membrane of the joints. It is characterized by chronic pain and joint destruction, which leads to premature mortality and risk of disability, with high costs to the patient and society. The case is presented of a young male patient with aplastic anemia since 8 years old who, in 2009, began with swelling and joint pain in the hands, wrists and ankles, fulfilling criteria for rheumatoid arthritis.


Subject(s)
Humans , Male , Adult , Arthritis, Rheumatoid , Anemia, Aplastic , Pain , Synovial Membrane
4.
Rev. argent. reumatol ; 24(3): 38-40, 2013.
Article in Spanish | LILACS | ID: biblio-835768

ABSTRACT

La enfermedad del suero constituye un síndrome clínico causado por la formación de complejos inmunes que generan una reacción de hipersensibilidad, con manifestaciones clínicas típicas de erupción cutánea, artritis, y fiebre que inician de 1 a 3 semanas después de la administración de un fármaco y suelen desaparecer al cabo de varios días de interrumpir la administración del agente causal, pudiendo persistir durante intervalos mayores, especialmente cuando son fármacos de acción prolongada o retardada. Se describe el caso de una paciente con síndrome de Sjõgren primario que presentó enfermedad del suero secundaria al uso de rituximab.


Serum sickness is a clinical syndrome caused by the formation of immune complexes that generate a hypersensitivity reaction. Typical manifestations are rashes, arthritis, and fever beginning within3 weeks after administration of a drug and usually disappear several days after the suppression of the causative agent, although theymight persist for longer periods, especially with long-acting drugs. We describe the case of a female patient with primary Sjogren'ssyndrome who presented secondary serum sickness after usingrituximab.


Subject(s)
Serum Sickness , Sjogren's Syndrome
SELECTION OF CITATIONS
SEARCH DETAIL
...